Background People who are prescribed self administered medications typically take only
about half their prescribed doses. Efforts to assist patients with adherence to medications …

Bisphosphonates are primary agents in the current pharmacological arsenal against
osteoclast-mediated bone loss due to osteoporosis, Paget disease of bone, malignancies …

Abstract Summary The International Osteoporosis Foundation (IOF) Capture the Fracture
Campaign aims to support implementation of Fracture Liaison Services (FLS) throughout the …

Dual-energy X-ray absorptiometry (DXA) was the first imaging tool widely utilized by
clinicians to assess fracture risk, especially in postmenopausal women. The development of …

Bisphosphonates are widely prescribed and highly effective at limiting the bone loss that
occurs in many disorders characterized by increased osteoclast-mediated bone resorption …

Bone turnover markers of resorption and formation are released during the process of bone
remodelling. These markers have been extensively studied in a number of therapeutic trials …

Background Osteoporosis is an abnormal reduction in bone mass and bone deterioration
leading to increased fracture risk. Alendronate belongs to the bisphosphonate class of …

The aim of treatment of postmenopausal osteoporosis is to reduce the frequency of vertebral
and non-vertebral fractures (especially at the hip), which are responsible for morbidity …

Background Systemic glucocorticoids are used in dermatologic practice for various diseases
including connective tissue disorders, bullous diseases, and many other dermatologic …

Osteoporosis increases the risk of fractures, which are associated with increased mortality
and lower quality of life. Patients with prevalent fracture are at high risk to of sustaining …